EMJ Podcast | Quickfire & Deep Dive
In this series, host Saranya Ravindran speaks with Peter J. Mogayzel about how the USA’s approach to cystic fibrosis has evolved, from newborn screening and therapeutic guidelines to equity challenges and future research. Together, they explore the systems, science, and stories shaping cystic fibrosis care worldwide, revealing what global collaboration can achieve for patients and clinicians alike.
Speaker Bio:
Peter J. Mogayzel is the Menowitz/Rosenstein Professor of Pediatric Respiratory Sciences at Johns Hopkins University School of Medicine and Director of the Johns Hopkins Cystic Fibrosis Center, Baltimore, Maryland, USA. Internationally recognised for his leadership in cystic fibrosis clinical guidelines and research on cystic fibrosis transmembrane conductance regulator modulation and mucociliary clearance, he has been instrumental in defining national standards of care in the USA.
